HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lisa M Deangelis Selected Research

Rituximab (Mabthera)

1/2013Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lisa M Deangelis Research Topics

Disease

14Neoplasms (Cancer)
01/2018 - 06/2006
9Lymphoma (Lymphomas)
03/2014 - 10/2004
9Glioblastoma (Glioblastoma Multiforme)
05/2013 - 01/2010
6Brain Neoplasms (Brain Tumor)
01/2019 - 09/2004
6Glioma (Gliomas)
02/2013 - 01/2010
3Meningioma (Meningiomas)
01/2010 - 12/2009
2Neurologic Manifestations (Neurological Manifestations)
05/2013 - 09/2004
1Central Nervous System Diseases (CNS Diseases)
01/2018
1Headache (Headaches)
05/2013
1Stroke (Strokes)
05/2012
1Lymphopenia (Lymphocytopenia)
08/2010
1Leukopenia
08/2010
1Fatigue
08/2010
1Thrombocytopenia (Thrombopenia)
08/2010
1Hemorrhage
08/2010
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2009
1Neuralgia (Stump Neuralgia)
04/2009
1Peripheral Nervous System Diseases (PNS Diseases)
04/2009
1Acquired Immunodeficiency Syndrome (AIDS)
09/2008
1Melanoma (Melanoma, Malignant)
01/2008
1Breast Neoplasms (Breast Cancer)
11/2007
1Neoplasm Metastasis (Metastasis)
11/2007
1Respiratory Insufficiency (Respiratory Failure)
04/2005

Drug/Important Bio-Agent (IBA)

5Temozolomide (Temodar)FDA LinkGeneric
05/2013 - 07/2011
4Methotrexate (Mexate)FDA LinkGeneric
03/2014 - 01/2006
3SteroidsIBA
05/2013 - 10/2004
3ErbB Receptors (EGF Receptor)IBA
10/2011 - 01/2010
3Anticonvulsants (Antiepileptic Drugs)IBA
01/2010 - 09/2004
3Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2010 - 01/2010
2Bevacizumab (Avastin)FDA Link
02/2013 - 04/2012
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2012 - 07/2011
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
04/2012 - 08/2010
2Tyrosine Kinase InhibitorsIBA
10/2011 - 08/2010
2Adrenal Cortex Hormones (Corticosteroids)IBA
10/2004 - 09/2004
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2019
1Cancer VaccinesIBA
01/2018
1Immune Checkpoint InhibitorsIBA
01/2018
1Antineoplastic Agents (Antineoplastics)IBA
01/2018
1GlucocorticoidsIBA
05/2013
1IGF-I-IGFBP-3 complexFDA Link
02/2013
1Rituximab (Mabthera)FDA Link
01/2013
1Tissue Plasminogen Activator (Alteplase)FDA Link
05/2012
1CilengitideIBA
01/2012
1Biomarkers (Surrogate Marker)IBA
12/2011
1Matrix Metalloproteinases (MMPs)IBA
12/2011
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
12/2011
1Lapatinib (GW572016)FDA Link
10/2011
1CholesterolIBA
10/2011
1Sterol Regulatory Element Binding Protein 1IBA
10/2011
1GW 3965IBA
10/2011
1epidermal growth factor receptor VIIIIBA
10/2011
1Liver X ReceptorsIBA
10/2011
1LDL Receptors (LDL Receptor)IBA
10/2011
1Phosphatidylinositols (Phosphatidylinositol)IBA
10/2011
1Endothelial Growth FactorsIBA
07/2011
1Proteins (Proteins, Gene)FDA Link
07/2011
1afliberceptIBA
07/2011
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2011
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
08/2010
1Angiogenesis InhibitorsIBA
08/2010
1pazopanibFDA Link
08/2010
1Gefitinib (Iressa)FDA Link
01/2010
1EnzymesIBA
01/2010
1Platelet-Derived Growth FactorIBA
12/2009
1Imatinib Mesylate (Gleevec)FDA Link
12/2009
1AntigensIBA
01/2008
1Capecitabine (Xeloda)FDA Link
11/2007
1Hormones (Hormone)IBA
04/2005
1GadoliniumIBA
04/2005
1AnticoagulantsIBA
09/2004

Therapy/Procedure

11Therapeutics
01/2018 - 09/2004
8Drug Therapy (Chemotherapy)
01/2012 - 10/2005
5Radiotherapy
05/2013 - 10/2005
1Contraindications
05/2012
1Drug Tapering
08/2010
1Salvage Therapy
07/2007